- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT01730066
Probiotics Against Pathogenic Bacteria in Advanced ENT-Surgery
Probiotics for Reduction of Pathogenic Bacteria in Connection With Advanced Surgery in the Mouth, the Oropharynx, and on the Neck
Surgery in the mouth and oropharynx is performed in an area colonised by bacteria non-pathogenic and pathogenic.
Antibiotics are used regularly resulting in disturbances in the intestinal microbiological flora and consequently diarrhoea that can be troublesome. The use of antibiotics throughout the hospital stay for these difficult cases represent a risk of development of resistant strains.
Most of the patients have cancer diagnoses and have radiation therapy before surgery. This increases the risk of the patients having pathogenic bacteria normally present in the lower GI-tract.
The investigators have shown for ICU patients that treatment with probiotics reduces the number of emerging enteral bacteria in the oropharynx and now the investigators will perform an adjusted procedure for patients planned for large ear, nose, and throat (ENT) surgery.
Patients will preoperatively gurgle a suspension of probiotics and then swallow the preparation.
Postoperatively the probiotics is given enterally and a eventually by mouth again.
Cultures will be taken from the oropharynx and tracheal secretions and the results will be compared
연구 개요
상태
상세 설명
Longer surgical procedures require intubation and there is a potential risk of contaminating the lower airways with pathogenic bacteria from the mouth and oropharynx.
Surgery including the mouth and the oropharynx is performed in an area that is colonised by hundreds of different bacterial species. In the healthy person there is a balance between the different microbes and possible pathogens are kept under control.
Patients that are subject to surgery in the mouth, oropharynx or neck area, most often have cancer diagnoses. Preoperative treatment (mostly radiation) is done in most cases resulting in a changed spectrum of bacteria in the mouth and oropharynx. Due to lowered appetite increased difficulties to eat, in combination with cancer diagnosis, there is also a change in cranial direction of the microbiological gut flora resulting in the presence of pathogens such as Gram-negative bacteria. Those species may result in troublesome infections in the postoperative period.
With healthy people pathogenic bacteria originating from the gastro/intestinal canal are seldom found in the oropharynx, but those do occur among many patients.
Antibiotics are used prophylactic and for more extensive surgery, as micro vascular procedures with free transplants of tissues, antibiotics are kept throughout the length of stay (LOS) in hospital. This results in an increased risk for the development of resistant bacteria and does result in changes in the GI flora in those patients. Diarrhoea occurs frequently and are troublesome for the patients For ICU patients we have seen a reduction of emerging enteric bacteria in patients given oral care with probiotics and this study will explore the possibility of the same kind of positive effects in patients due for extensive surgery performed during several hours.
Many of the patients will have a tracheostomy performed as part of the surgical procedure.
Patients will be randomised (1:1) to either no prophylaxis (standard procedure today) or to preparation with a probiotic suspension fro the day before surgery until discharge from hospital.
Preoperatively the patients will gurgle a suspension of probiotics and then swallow the preparation.
Postoperatively the probiotics is given enterally and a eventually when the responsible surgeon find it suitable by mouth again.
Cultures at inclusion, after intubation, and then on predefined days postoperatively to compare bacterial flora in the oropharynx and in tracheal secretions.
Infectious parameters will be followed.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Lund, 스웨덴, SE 22185
- Lund University Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Elective advanced and extensive ENT surgery
- Adult patients (≥ 18 years)
- Surgery requires general anesthesia and endotracheal intubation
- Length of anesthesia ≥ 1,5 hours
- Signed informed consent
Exclusion Criteria:
- Ongoing treatment requiring infection in the lower respiratory tract
- Chronic lung disease requiring oxygen treatment
- Known immune deficiency
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 방지
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: Probiotics
Patients will gurgle and swallow a mixture of probiotic bacteria preoperatively and given the same study product enterally postoperatively
|
Patients will be given a mixture of maltodextrin ( a starch product often used i alimentary products) and two strains of probiotic bacteria ( L. plantarum 299 and L. plantarum 299v ) dissolved in water. They will gurgle and swallow the suspension from the day before surgery. Postoperatively they will be given the probiotic mixture via a nasogastric tubing twice a day and when the responsible surgeon find it suitable also orally as described above. When they can swallow no study product is given through the nasogastric tube. Patients randomized 1:1 between groups |
간섭 없음: Control
No intervention.What has been the standard procedure so far
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Differences in pathogenic bacteria in the oropharynx
기간: During hospitalization, anticipated mean time 12 days
|
Emerging and resident bacteria will be compared for the cultures taken in the oropharynx and from tracheal secretions in connection to a surgical intervention and postoperatively
|
During hospitalization, anticipated mean time 12 days
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
활착
기간: 6개월
|
참여 환자의 경우 28일 및 180일(6개월)의 생존 또는 비생존 상태가 기록됩니다.
|
6개월
|
White Blood Cell count
기간: During hospital stay, expected mean LOS 12 days
|
WBC taken pre-op and then on predefined days postoperatively
|
During hospital stay, expected mean LOS 12 days
|
C Reactive Protein
기간: Throughout the hospital stay, expected mean LOS 12 days
|
CRP taken pre-op and then on predefined days postoperatively
|
Throughout the hospital stay, expected mean LOS 12 days
|
Length of Hospital stay
기간: Participants will be followed for the duration of hospital stay, an expected average of 2-3 weeks
|
Length of stay is recorded for the Hospital stay, and for those cases that have an extended post-operative period in the ICU, the length of the ICU stay will be recorded
|
Participants will be followed for the duration of hospital stay, an expected average of 2-3 weeks
|
Diarrhoea and obstipation
기간: Throughout the hospital stay, expected mean LOS 12 days
|
As ICU patients tend to display diarrhoea as well as obstipation the frequency and consistency of stools will be recorded. Probiotics are anticipated to stabilise bowel function |
Throughout the hospital stay, expected mean LOS 12 days
|
공동 작업자 및 조사자
간행물 및 유용한 링크
일반 간행물
- Stjernquist-Desatnik A, Warfving H, Johansson ML. Persistence of Lactobacillus plantarum DSM 9843 on human tonsillar surface after oral administration in fermented oatmeal gruel. A pilot study. Acta Otolaryngol Suppl. 2000;543:215-9. doi: 10.1080/000164800454422.
- Klarin B, Molin G, Jeppsson B, Larsson A. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study. Crit Care. 2008;12(6):R136. doi: 10.1186/cc7109. Epub 2008 Nov 6.
유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- ProOncENT
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Advanced ENT Surgery에 대한 임상 시험
-
University Hospital, Strasbourg, France모병Cervico-Facial Surgery ENT 프랑스의 학술 의료 및 외과 교육 | Cervico-Facial Surgery ENT Medical 레지던트(Auvergne-Rhône-Alpes, Grand Est, Ile de France, Nouvelle Aquitaine 및 Provence-Alpes-Côte d'Azur 지역)프랑스
-
Pharmaceutical Project Solutions, Inc.아직 모집하지 않음
-
Assistance Publique Hopitaux De Marseille완전한심혈관 질환 | 비만 환자 | Bariatric Surgery 전후의 이러한 TRL의 생성률프랑스
-
Dong Yang알려지지 않은복강경 보조 수술 | 절개 없는 복강경 전수술(Natural Orifice Transluminal Endoscopic Surgery, NOSES)중국
-
Institut Rosell LallemandBioFortis완전한
-
Töölö HospitalTurku University Hospital; Tampere University Hospital; Jyväskylä Central Hospital; Kymenlaakso...모병
-
Carmel Medical CenterUniversity of Haifa알려지지 않은
-
Advanced Bionics완전한심한 청력 손실 | Advanced Bionics HiResolution™ Bionic Ear System의 성인 사용자미국
L. plantarum 299 and L. plantarum 299v (+maltodextrin)에 대한 임상 시험
-
Region SkaneLund University종료됨
-
Rijnstate HospitalWageningen University; NIZO Food Research; Allergologiepraktijk Arnhem/Radboud/Rijnstate; Campina...완전한
-
G. d'Annunzio UniversityProbiotical S.p.A.아직 모집하지 않음